Attached herewith Financial Results for FY 24-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evexia Lifecare's board, which met on May 30, 2025, approved the audited financial results (standalone and consolidated) for the quarter and full financial year ended March 31, 2025. Alongside the results, the board appointed Ms. Krupalibahen Rajeshbhai Mehta (DIN: 11109785) as an Additional Non-Executive Independent Director for a 5-year term, subject to shareholder approval. She is not related to any existing director, KMP, or promoter of the company, and is not debarred by SEBI or any other authority. Notably, the auditor's report on these results is a qualified report, and the company has attached a Statement on Impact of Audit Qualifications, which is a point investors should review carefully. Detailed financial numbers, balance sheet, and cash flow statements were submitted as enclosures and are not included in this letter.
The qualified audit opinion is a concern — it indicates the auditors flagged issues in the financial statements that investors should examine before drawing conclusions on the company's reported numbers. The independent director appointment is routine governance and does not alter promoter control.